Caterina Cavanna

Dr. Caterina Cavanna

orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
ATAnna Maria Tortorano
Anna Maria Tortorano
MEMaria Carmela Esposto
Maria Carmela Esposto
APAnna Prigitano
Anna Prigitano
AGAnna Grancini
Anna Grancini
COCristina Ossi
Cristina Ossi
GCGiuliana Lo Cascio
Giuliana Lo Cascio
Nine of 11 hematological patients with disseminated/deep-seated Fusarium infection tested at least twice for Aspergillus galactomannan (GM) had repeated positive results in the absence of Aspergillus isolation in culture. The centrifuged supernatants of 12 Fusarium isolates were tested by a GM enzyme-linked immunosorbent assay (EIA). All the isolates produced positive reactions when tested undiluted. These results show cross-reactivity of Fusarium spp. with Aspergillus GM that may constitute a drawback with respect to the specificity of the Platelia EIA.

12 June 2011 in Mycoses
Verified
Journal Article
Closed access
PDF file
ATAnna Maria Tortorano
Anna Maria Tortorano
GDGiovanna Dho
Giovanna Dho
APAnna Prigitano
Anna Prigitano
GBGiuseppe Breda
Giuseppe Breda
AGAnna Grancini
Anna Grancini
FGfor the ECMM‐FIMUA Study Group
for the ECMM‐FIMUA Study Group

10 August 2007 in Mycoses
Verified
Journal Article
Closed access
PDF file
FPFabio Pagella
Fabio Pagella
EMElina Matti
Elina Matti
FBFrancesca De Bernardi
Francesca De Bernardi
LSLucia Semino
Lucia Semino
CCCaterina Cavanna
Caterina Cavanna
PCPaolo Giocondo Maria Castelnuovo
Paolo Giocondo Maria Castelnuovo

1 August 2002 in Journal of Hospital Infection
Verified
Journal Article
Closed access
PDF file
ATAnna Maria Tortorano
Anna Maria Tortorano
EBE. Biraghi
E. Biraghi
AAA. Astolfi
A. Astolfi
COC. Ossi
C. Ossi
MTM. Tejada
M. Tejada
AGA. Grossi
A. Grossi

3 May 2014 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
OGOn the behalf of the ECMM Working Group
On the behalf of the ECMM Working Group
ATAnna Maria Tortorano
Anna Maria Tortorano
APA. Prigitano
A. Prigitano
MEM. C. Esposto
M. C. Esposto
VAV. Arsic Arsenijevic
V. Arsic Arsenijevic
MDMaria Drogari-Apiranthitou
Maria Drogari-Apiranthitou

1 January 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
AEAna Espinel-Ingroff
Ana Espinel-Ingroff
JTJ. Turnidge
J. Turnidge
Ana Alastruey-IzquierdoAna Alastruey-Izquierdo
Ana Alastruey-Izquierdo
FBF. Botterel
F. Botterel
ECE. Canton
E. Canton
MTM. Tejada
M. Tejada
Although the Sensititre Yeast-One (SYO) and Etest methods are widely utilized, interpretive criteria are not available for triazole susceptibility testing of Candida or Aspergillus species. We collected fluconazole, itraconazole, posaconazole, and voriconazole SYO and Etest MICs from 39 laboratories representing all continents for (method/agent-dependent) 11,171 Candida albicans , 215 C. dubliniensis , 4,418 C. glabrata species complex, 157 C. guilliermondii ( Meyerozyma guilliermondii ), 676 C. krusei ( Pichia kudriavzevii ), 298 C. lusitaniae ( Clavispora lusitaniae ), 911 C. parapsilosis sensu stricto , 3,691 C. parapsilosis species complex, 36 C. metapsilosis , 110 C. orthopsilosis , 1,854 C. tropicalis , 244 Saccharomyces cerevisiae , 1,409 Aspergillus fumigatus , 389 A. flavus , 130 A. nidulans , 233 A. niger , and 302 A. terreus complex isolates.